-
Some X-factor inhibitors, which have the advantage to be given orally in a fixed dose and don’t require any coagulation monitoring (differently from warfarin) are under study. Some examples of these drugs are rivaroxaban and apixaban.
MedNews (Angiology) - Tue, 9 March 2010
http://mn.medsurfnews.com/
-
There are not clear data yet on the incidence and the risk factors of a post-thrombotic syndrome after an episode of deep venous thrombosis (DVT). Through a prospective cohort trial, 387 patients with DVT in eight hospitals in Canada have been treated with heparin followed by warfarin and monitored after 1, 4, 8, 12 and 24 months.
MedNews (Angiology) - Fri, 15 May 2009
http://mn.medsurfnews.com/
-
The results of a randomized trial suggest that statins may be a useful treatment for Raynaud's phenomenon and digital ulcers that can accompany systemic sclerosis.
Medscape (Angiology) - Wed, 24 September 2008
http://www.medscape.com
-
Researchers are reporting that microembolism of foam particles is common during foam sclerotherapy for varicose veins, and among patients with patent foramen ovale (PFO), these microemboli might be linked to neurologic symptoms.
Medscape (Angiology) - Fri, 4 April 2008
http://www.medscape.com
-
Objective of the study is to identify single-nucleotide polymorphisms (SNPs) associated with DVT.
Journal of the American Medical Association (Angiology) - Wed, 19 March 2008
http://jama.ama-assn.org/
-
One way of combating atherosclerosis is to reduce levels of "bad cholesterol" in the blood. Scientists at the Swedish medical university Karolinska Institutet have now identified the genes that bring about this beneficial effect.
Karolinska Institutet (Angiology) - Wed, 19 March 2008
http://ki.se/ki/jsp/polopoly.jsp?d=130&l=en
-
The long-acting factor X inhibitor idraparinux was compared with a standard antithrombotic regimen in two randomized trials, one for the treatment of deep venous thrombosis (DVT Study) and the other for the treatment of pulmonary embolism (PE Study).
New England Journal of Medicine (Angiology) - Thu, 13 September 2007
http://www.nejm.org
-
Even if the codified period of treatment for venous thromboembolism is of three months, it is still discussed whether is it opportune to continue therapy beyond this term.
MedNews (Angiology) - Tue, 11 September 2007
http://mn.medsurfnews.com/
-
The standard treatment of Kawasaki disease uses intravenous immunoglobulins associated with ASA, while favourable results obtained with cortisone in complicated forms of the disease have driven some clinicians to add these substances to the basic therapy of the disease.
MedNews (Angiology) - Sun, 29 July 2007
http://mn.medsurfnews.com/
-
WHO today released results from Phase I of the WHO Research Into Global Hazards of Travel (WRIGHT) project. Findings indicate that the risk of developing venous thromboembolism (VTE) approximately doubles after travel lasting four hours or more.
World Health Organization (Angiology) - Thu, 5 July 2007
http://www.who.int